Concepedia

Emily Latuske

EL

Statistics

Publications

4

Citations

243

H-Index

4

Active since

2015

Affiliations

University Medical Center Hamburg-Eppendorf(Current)

University Cancer Center Hamburg

Universität Hamburg

Medizinische Hochschule Hannover

Emily Latuske is an author at University Medical Center Hamburg-Eppendorf specializing in molecular oncology, acute myeloid leukemia therapy, and medicine.

Publications per year

2015–2018

4

Publications

4

Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option

Hauke Stamm, Felix Klingler, Eva-Maria Grossjohann et al. · Oncogene · 2018 · 107 citations · Full text

, , +17

Expression of Hedgehog Pathway Mediator <i>GLI</i> Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects

Jasmin Wellbrock, Emily Latuske, Julian Köhler et al. · Clinical Cancer Research · 2015 · 103 citations · Full text

, , +17

SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model

Maike Täger, Stefan Horn, Emily Latuske et al. · Gene Therapy · 2017 · 21 citations

, , +15

Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia

Nicole Degwert, Emily Latuske, Gabi Vohwinkel et al. · European Journal Of Haematology · 2015 · 12 citations

, , +17

1–4 of 4